Figure 2.
Incremental antihypertensive effects following a direct switch to amlodipine/valsartan 5/160 mg and 10/160 mg in patients with hypertension previously uncontrolled with monotherapy. Mean change from baseline in mean sitting systolic and diastolic blood pressure (MSSBP and MSDBP, respectively) and the proportion of patients in whom blood pressure (BP) control* was achieved over time (intent‐to‐treat population).*BP control is defined as BP <140/90 mm Hg for nondiabetic patients and <130/80 mm Hg for diabetic patients.